Long-Term Vutrisiran Reduces Cardiovascular Events And Hospitalizations In Patients With Transthyretin Cardiac Amyloidosis In The HELIOS-B One-Year Open Label Extension

Vyndaqel (tafamidis meglumine) - Pfizer

Amvuttra (vutrisiran) - Alnylam

https://eppro02.ativ.me/web/page.php?page=QuarentinedIntHtml&project=HFSA26&id=60

Sarah A. M. Cuddy1; Jan M. Griffin2; Wai Hong Tang3; Olivier Lairez4; Caroline Morbach5; Francesco Cappelli6; Farooq H. Sheikh7; Hua Zheng8; Benjamin W. Lee8; Alisa R. Kosheleff8; Ronald Witteles9

Sep 7, 2026